Ceredex Value Advisors LLC Baxter International Inc Transaction History

Ceredex Value Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$49.7 - $57.71 $17.9 Million - $20.8 Million	-360,418 Reduced 27.58%	946,295 $0
Q3 2022 Nov 07, 2022	SELL	$53.86 - $66.8 $44.7 Million - $55.5 Million	-830,824 Reduced 38.87%	1,306,713 $70.8 Million
Q2 2022 Aug 03, 2022	BUY	$63.83 - $80.0 $62.4 Million - $78.2 Million	978,120 Added 84.36%	2,137,537 $138 Million
Q1 2022 May 05, 2022	BUY	$76.85 - $89.45 $89.1 Million - $104 Million	1,159,417 New	1,159,417 $90.2 Million

985

450M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $15.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Ceredex Value Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Ceredex Value Advisors LLC with notifications on news.